AN2 Therapeutics (ANTX) Shares Issued (2021 - 2026)
AN2 Therapeutics (ANTX) reported Shares Issued of $24000.0 for Q1 2026, down 36.84% year-over-year from $38000.0 in Q1 2025, and down 50.0% quarter-over-quarter from $48000.0 in Q3 2025.
AN2 Therapeutics (ANTX) Shares Issued (2021 - 2026) Analysis & Trends
AN2 Therapeutics (ANTX) has 6 years of Shares Issued data on file, last reported at $24000.0 in Q1 2026.
- Shares Issued for Q1 2026 came in at $24000.0, down 36.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $72000.0 (down 48.2% YoY), and the FY2025 annual result was $86000.0, down 61.78% from the prior year.
- Shares Issued fell to $24000.0 in Q1 2026 per ANTX's latest filing, from $48000.0 in the prior quarter.
- Over five years, Shares Issued peaked at $63.2 million in Q1 2022 and troughed at -$10000.0 in Q3 2022.
- A 5-year average of $9.0 million and a median of $112500.0 in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2023: Shares Issued soared 631880.0% in 2022, then plunged 99.69% in 2023.
- A 5-year view of Shares Issued shows it stood at -$10000.0 in 2022, then jumped by 190110.0% to $19.0 million in 2023, then tumbled by 99.47% to $101000.0 in 2024, then tumbled by 52.48% to $48000.0 in 2025, then sank by 50.0% to $24000.0 in 2026.
- Business Quant data shows ANTX's Shares Issued at $24000.0 in Q1 2026, $48000.0 in Q3 2025, and $38000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 26,927.15 |
| 10 | AN2 Therapeutics | 161.95 Mn | 161.95 Mn | - | 24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,000.00 |
| Mar 31, 2026 | 24,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Jun 30, 2024 | 101,000.00 |
| Jun 30, 2024 | 101,000.00 |
| Mar 31, 2024 | 124,000.00 |
| Mar 31, 2024 | 124,000.00 |
| Dec 31, 2023 | 19.00 Mn |
| Dec 31, 2023 | 19.00 Mn |
| Mar 31, 2023 | 199,000.00 |
| Mar 31, 2023 | 199,000.00 |
| Sep 30, 2022 | -10,000.00 |
| Sep 30, 2022 | -10,000.00 |
| Jun 30, 2022 | 7.18 Mn |
| Jun 30, 2022 | 7.18 Mn |
| Mar 31, 2022 | 63.20 Mn |
| Mar 31, 2022 | 63.20 Mn |